Cercone Melissa A, Schroeder William, Schomberg Stacey, Carpenter Todd C
Developmental Lung Biology Laboratory, Box B-131, Department of Pediatrics, University of Colorado School of Medicine, 12700 East 19th Ave., Aurora, CO 80045, USA.
Am J Physiol Lung Cell Mol Physiol. 2009 Nov;297(5):L856-63. doi: 10.1152/ajplung.00118.2009. Epub 2009 Aug 14.
Ephrin family receptor tyrosine kinases are mediators of angiogenesis that may also regulate endothelial barrier function in the lung. Previous work has demonstrated that stimulation of EphA ephrin receptors causes increased vascular leak in the intact lung and increased permeability in cultured endothelial cells. Whether EphA receptors are involved in the permeability changes associated with lung injury is unknown. We studied this question in young rats exposed to viral respiratory infection combined with exposure to moderate hypoxia, a previously described lung injury model. We found that the EphA2 receptor is expressed in normal lung and that EphA2 expression is markedly upregulated in the lungs of hypoxic infected (HV) rats compared with normal control animals. Immunohistochemistry showed increased EphA2 expression principally in areas of edematous alveolar septae. In HV rats, EphA2 antagonism with either the soluble decoy receptor EphA2/Fc or with monoclonal anti-EphA2 antibody reduced albumin extravasation and histological evidence of edema formation (P<0.01). Vascular leak in HV rats is mediated in large part by increased lung endothelin (ET) levels. In HV rats, ET receptor antagonism with bosentan resulted in reduced EphA2 mRNA and protein expression (P<0.01). Experiments with cultured rat lung microvascular endothelial cells demonstrated that ET increases endothelial EphA2 expression. These results suggest that EphA2 expression is increased in lung injury, contributes to vascular leak in the injured lung, and is regulated in endothelial cells by ET. EphA2 may be a previously unrecognized contributor to the pathophysiology of lung injury.
Ephrin家族受体酪氨酸激酶是血管生成的介质,也可能调节肺内皮屏障功能。先前的研究表明,刺激EphA ephrin受体会导致完整肺中血管渗漏增加以及培养的内皮细胞通透性增加。EphA受体是否参与与肺损伤相关的通透性变化尚不清楚。我们在暴露于病毒性呼吸道感染并伴有中度缺氧的幼鼠中研究了这个问题,这是一种先前描述的肺损伤模型。我们发现EphA2受体在正常肺中表达,与正常对照动物相比,EphA2在缺氧感染(HV)大鼠肺中的表达明显上调。免疫组织化学显示EphA2表达增加主要在水肿性肺泡间隔区域。在HV大鼠中,用可溶性诱饵受体EphA2/Fc或单克隆抗EphA2抗体拮抗EphA2可减少白蛋白外渗和水肿形成的组织学证据(P<0.01)。HV大鼠的血管渗漏在很大程度上是由肺内皮素(ET)水平升高介导的。在HV大鼠中,用波生坦拮抗ET受体导致EphA2 mRNA和蛋白表达降低(P<0.01)。对培养的大鼠肺微血管内皮细胞的实验表明,ET可增加内皮细胞EphA2的表达。这些结果表明,EphA2在肺损伤中表达增加,导致受损肺中的血管渗漏,并在内皮细胞中受ET调节。EphA2可能是肺损伤病理生理学中一个先前未被认识的因素。